Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.26 USD | -2.89% | -2.98% | -11.41% |
Apr. 22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
Mar. 28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.41% | 3.43B | |
+4.16% | 32.45B | |
+12.62% | 7.26B | |
+20.83% | 3.84B | |
-27.11% | 1.31B | |
-34.31% | 1.11B | |
+4.25% | 919M | |
-23.45% | 856M | |
-38.17% | 840M | |
-17.86% | 712M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 Revenue $248.4M, vs. Street Est of $236.5M